MAKE SURE YOUR DENTIST IS AN ADA MEMBER!:
ADA Members Adhere to Strict Code of Ethics and Conduct. You should make sure you are SEEING AN ADA MEMBER DENTIST!
Visit ADA Find-A-Dentist to Find One Near YOU
Ninth District Headquarters Office - Hawthorne, NY
2025 Ninth District President
Dr. Renuka Bijoor
ADA Update: a new login experience
We’re updating how you log in to your NYSDA and ADA account.
Life comes with challenges, but your new Member Assistance Program (MAP) is here to help. This free, confidential benefit is available to you and your household, offering resources and services to support mental health, reduce stress, and make life easier.
The Ninth District Dental Society was formed in 1909 and renamed to the Ninth District Dental Association in 2002. We have a membership of over 1500 dentists in 5 counties: Westchester, Rockland, Dutchess, Orange and Putnam.
In its quest to serve both the public and the profession, the Ninth District embodies the highest ideals.
The mission of the 9th District Dental Association is to serve and support its members and the public by improving the oral health of our community through Advocacy, Continuing Education and Camaraderie.
The Ninth District Dental Association, in Partnership with the New York State Dental Foundation (NYSDF), will be hosting an
Oral Health Screening Event with the Hudson Valley Renegades and Sponsored by Henry Schein Cares Foundation
September 5, 2025 6:00 pm - 9:00 pm
* * * * * * * * * *
Don't Miss the 9th District Dental Association's General Meeting Wednesday, September 17, 2025
The Westchester Manor 140 Saw Mill River Road Hastings-on-Hudson, NY
Mahnaz Fatahzadeh, D.M.D., M.S.D. Completed her Oral Medicine fellowship and MSD degree at the
Rutgers School of Dental Medicine where she holds a faculty appointment as a
professor of Oral Medicine and as an attending at the University hospital. Dr.
Fatahzadeh is a diplomat of American Board of Oral Medicine and director of pre
and post-doctoral oral medicine training and Oral Mucosal Diseases Clinic at
the Rutgers School of Dental Medicine.
"Orofacial Manifestations of Systemic Diseases"
Course Objectives
Oral cavity is readily accessible for inspection and a gateway for
assessment of general health. In fact, many systemic conditions affecting
organs far from the head and neck region could manifest in the orofacial region,
sometimes prior to their diagnosis. Abnormalities detected in the orofacial
region may also represent complications related to medical therapy or raise
concerns about substance abuse. This program provides illustrative examples of
orofacial findings associated with diagnosed or subjectively silent systemic
disease, medical therapy and substance abuse. Relevant signs, symptoms, and
diagnostics are reviewed and the potential role of oral health care providers in
recognition, referral, follow-up and overall management is emphasized.
Meeting
Exhibitors (so far): (company
names are links to their websites)
The United States Food and Drug Administration (FDA) has issued its weekly regulatory update for stakeholders. You can read the FDA regulatory update for stakeholders below.
June 14, 2024
Dear Colleague,
While the FDA continues to focus on protecting the public’s health, using science to guide our decisions, and facilitating access to critical medical products, we also recognize the work of our public health partners. As public health advocates, we know that your work to better our country is invaluable. Your partnership, knowledge and engagement in the public health space are appreciated.
Advisory Committees Give FDA Critical Advice and the Public a Voice
At the U.S. Food and Drug Administration, we rely on our many advisory committees to help us make sound decisions based on the best science available.
The FDA’s complex and multifaceted mission includes evaluating new medical devices and medicines, including vaccines and other therapies, to determine if they are safe and effective for their intended use.
This edition of the Conversations on Cancer public panel discussion series will start with a brief exploration of the difference between religion and spirituality.
The FDA is announcing the following public workshop entitled " Evaluating Immunosuppressive Effects of In Utero Exposure to Drug and Biologic Products."
The Stakeholder Engagement Staff resides within the Office of the Commissioner and falls under the Office of External Affairs. We aim to build stronger relationships with health professional organizations, consumer groups, trade associations, patient advocacy organizations, think tanks/academia, and other stakeholders, in order to better inform our policy making process, identify policy hurdles or stakeholder misconceptions, and create strategic collaborations. For more information, please contact us at: FDAStakeholderEngagement@fda.hhs.gov.